Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Rapid Micro Biosystems, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +3 vs. Q3 2023
- Shares held
- 20.1M
- −1.36M (−6.4%) vs. Q3 2023
- Total value
- $14.9M
- −$8.31M (−35.8%) vs. Q3 2023
- New holders
- 5
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $6.24M | 0.60% | 00.0% | Unchanged |
| Kennedy Lewis Management LP | 4,939,931 | $3.66M | 20.25% | 00.0% | Unchanged |
| Glenview Capital Management, LLC | 1,318,288 | $975.5K | 0.02% | 00.0% | Unchanged |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $768.3K | 1.50% | 00.0% | Unchanged |
| BlackRock Inc. | 1,021,457 | $755.9K | 0.00% | −661−0.1% | Reduced |
| JPMorgan Chase & Co | 751,312 | $556.0K | 0.00% | −682,916−47.6% | Reduced |
| Vanguard Group Inc | 728,374 | $539.0K | 0.00% | +2,350+0.3% | Added |
| Adage Capital Partners GP, L.L.C. | 700,000 | $518.0K | 0.00% | 00.0% | Unchanged |
| Advent International Corp | 577,777 | $427.6K | 0.01% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 218,287 | $161.5K | 0.00% | −729,494−77.0% | Reduced |
| Geode Capital Management, LLC | 155,264 | $114.9K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 77,887 | $58.0K | 0.00% | +55,500+247.9% | Added |
| State Street Corp | 26,074 | $19.3K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 24,135 | $17.9K | 0.00% | +7,494+45.0% | Added |
| Millennium Management LLC | 17,175 | $12.7K | 0.00% | −7,810−31.3% | Reduced |
| Virtu Financial LLC | 16,064 | $12.0K | 0.00% | +16,064 | New |
| Northern Trust Corp | 15,650 | $11.6K | 0.00% | −3,294−17.4% | Reduced |
| Morgan Stanley | 10,644 | $7.88K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 10,463 | $7.74K | 0.00% | +10,463 | New |
| Tower Research Capital LLC (TRC) | 9,807 | $7.26K | 0.00% | +6,655+211.1% | Added |
| Wells Fargo & Company | 154 | $114 | 0.00% | +8+5.5% | Added |
| Advisory Services Network, LLC | 100 | $74 | 0.00% | +100 | New |
| Bank of America Corp | 14 | $10 | 0.00% | +14 | New |
| Qube Research & Technologies Ltd | 4 | $3 | 0.00% | 00.0% | Unchanged |
| Resources Management Corp | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 250 | $0 | 0.00% | +250 | New |
| Parkwood LLC | 0 | $0 | 0.00% | −24,511−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |